References
Nickson C, Mason KE, Kavanagh AM (2014) Breast cancer screening of women aged 70–74 years: results from a natural experiment across Australia. Breast Cancer Res Treat 143(2):367–372
Australian Institute of Health and Welfare & National Breast Cancer Centre (2007) Breast cancer survival by size and nodal status in Australia. Australian Institute of Health and Welfare, Canberra
Thursfield V, Farrugia H, Karahalios E, Giles G (2012) Cancer in survival Victoria 2012: estimates of survival for 2006–2010 (and comparisons with earlier periods). Cancer Council Victoria, Melbourne
Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, ICBP Module 1 Working Group et al (2013) Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer 108(5):1195–1208
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717
Burton RC, Bell RJ, Thiagarajah G, Stevenson C (2012) Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 131(3):949–955
White V, Pruden M, Giles G, Collins J, Jamrozik K, Inglis G, Boyages J, Hill D (2004) The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 101(3):476–485
Australian Institute of Health and Welfare (AIHW) (2014). http://www.aihw.gov.au/collection-of-mortality-data
Roder DM, Olver IN (2012) Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?–yes. Med J Aust 196(1):16
Nickson C, Mason KE, English DR, Kavanagh AM (2012) Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(9):1479–1488
Author information
Authors and Affiliations
Corresponding author
Additional information
This rebuttal letter refers to the letter to the editor available at 10.1007/s10549-014-2948-0
Rights and permissions
About this article
Cite this article
Nickson, C., Mason, K.E. & Kavanagh, A.M. Rebuttal to: Letter to the Editor by Robert Burton, in response to doi:10.1007/s10549-013-2794-5. Breast Cancer Res Treat 145, 565–566 (2014). https://doi.org/10.1007/s10549-014-2952-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-2952-4